Skip to main content

H.R. 8646 – Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

Wednesday, June 3, 2026

PASSED 213-210

Agreed to by Voice Vote

Bipartisan En Bloc #1 (Boebert #1, Boebert #2, Boebert #3, Boebert #4, Boebert #5, Buchanan #6, Figures #7, Figures #8, Flood #9, Gosar #10, Leger Fernández #11, Malliotakis #12, Malliotakis #13, Ogles #14, Pettersen #16, Stanton #17, Stanton #18, Subramanyam #21, Sykes #22, Thompson (CA) #23, Thompson (PA) #24, Vasquez #25, Vindman #26) 

Not Offered

Ogles #15  Prevents FDA from requiring a separate REMS safety program for a biosimilar when FDA has already determined the biosimilar and reference product present the same serious risks and require the same safety controls. It reduces duplicative regulatory burdens that can delay lower-cost biosimilar competition without weakening FDA’s underlying safety authority
Steube #19  Strikes funding ($900,000,000) for Food for Peace Title II Grants, transfers to Spending Reduction Account
Steube #20  Strikes provision providing $240,000,000 for the McGovern-Dole International Food for Education and Child Nutrition Program Grants